XX-650-23
XX-650-23 is a potent CREB inhibitor. XX-650-23inhibits CREB function through disruption of CBP-CREB interaction. XX-650-23 can be used for AML research[1].
Product Specifications
CAS Number
117739-40-9
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xx-650-23.html
Purity
99.90
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(C=C2C=CC=CC2=C1)O)NC3=CC=C(C=C3)C#N
Molecular Formula
C18H12N2O2
Molecular Weight
288.30
References & Citations
[1]B Mitton, et al. Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells. Leukemia. 2016 Dec;30 (12) :2302-2311.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681820-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881825-500 1x 500 µL
Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/1825R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041012-100 1x 100 µL
S100B (S100B/1012), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740413-100 1x 100 µL
Chromogranin A (CHGA/413), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401725-100 1x 100 µL
Glycophorin A / CD235a (Erythrocyte Marker) (GYPA/1725R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details